Impact of Enhanced Information on Subjective Information Level and PROMs in Patients with Aortic Stenosis
NCT ID: NCT06706635
Last Updated: 2024-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
250 participants
INTERVENTIONAL
2024-08-21
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
NCT04414865
In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation
NCT06859255
Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAVI Outcome - (German Pilot)
NCT03570190
Detection of Aortic Stenosis With Smartphone Auscultation Using Machine Learning (HEARTBEAT-Pilot)
NCT06404437
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
NCT03056573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Full access to a mobile App
Study patients will receive full access to a mobile App
Application of App
Full Access to Mobile App
Restricted access to a mobile App
Study patients will receive restricted access to a mobile App
Application of App
Full Access to Mobile App
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Application of App
Full Access to Mobile App
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* planned aortic valve replacement (TAVI)
* Patient is willing and able to complete the surveys in German language
* Written informed consent by the trial subject
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart and Diabetes Center North-Rhine Westfalia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW
Bad Oeynhausen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tanja K. Rudolph, MD
Role: backup
Sara Waezsada, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HDZ-KA_023_TR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.